Advancements in AI, multi-omics, and genome editing are transforming life sciences and biotechnology, addressing new ...

Kazia Therapeutics , an oncology-focused pharmaceutical company developing novel therapies for difficult-to-treat cancers, ...

Data identify nuclear PD-L1 as a previously unaddressed driver of immunotherapy resistance and metastatic progression SYDNEY, Jan. 30, 2026 /PRNewswire/ -- Kazia ...

Accurate risk stratification and treatment selection remain central challenges in cancer care. Rapid advances in medical imaging, digital pathology, and ...

Collaboration with Dana-Farber Cancer Institute aims to identify biomarkers linked to treatment response for the next generation of cancer therapies and to define a clinical reporting framework to ...

PLEASANTON, Calif., Jan. 12, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced a collaboration with Dana-Farber Cancer Institute to ...

Spatial intelligence, a frontier technology, is essential for AI to enable humanoids and autonomous vehicles to operate in the physical world.

Candida auris is an emerging threat, primarily to hospital patients and residents of nursing homes. The fungus easily spreads, colonizes surfaces and objects where it can survive for weeks to months, ...

In recent years, numerous landslides on hillsides in urban and rural areas have underscored that understanding and predicting ...

Data-driven AI systems increasingly influence our choices, raising concerns about autonomy, fairness, and accountability. Achieving algorithmic autonomy requires new infrastructures, motivation ...